MiNK Therapeutics, Inc. — Investor Relations & Filings
MiNK Therapeutics, Inc. is a clinical-stage biopharmaceutical company pioneering the development of allogeneic invariant natural killer T (iNKT) cell therapies for cancer and other immune-mediated diseases. The company's platform harnesses the dual properties of iNKT cells, which combine the potent cytotoxicity of natural killer (NK) cells with the lasting memory response of T cells to enhance both innate and adaptive immunity. Its lead product candidate, AGENT-797, is an off-the-shelf therapy administered without requiring lymphodepletion or HLA matching. It is currently in clinical trials for solid tumors, severe acute respiratory distress syndrome (ARDS), and Graft versus Host Disease (GvHD). MiNK is also developing a next-generation technology platform for engineered iNKT cells and bispecific iNKT cell engagers for precision targeting.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2024-10-18 | English | |
| 8-K | 2024-09-13 | English | |
| 4 | 2024-09-05 | English | |
| 4 | 2024-09-05 | English | |
| 4 | 2024-09-05 | English | |
| 4 | 2024-09-05 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 13360711 | 8-K | 2024-10-18 | English | ||
| 13360712 | 8-K | 2024-09-13 | English | ||
| 13360713 | 4 | 2024-09-05 | English | ||
| 13360714 | 4 | 2024-09-05 | English | ||
| 13360715 | 4 | 2024-09-05 | English | ||
| 13360716 | 4 | 2024-09-05 | English | ||
| 13360717 | 8-K | 2024-08-30 | English | ||
| 13360718 | Regulatory Filings 2024 | 2024-08-19 | English | ||
| 13360719 | 424B3 | 2024-08-16 | English | ||
| 13360720 | Regulatory Filings 2024 | 2024-08-15 | English | ||
| 13360721 | Regulatory Filings 2024 | 2024-08-15 | English | ||
| 13360722 | S-3 | 2024-08-13 | English | ||
| 13360723 | S-8 | 2024-08-13 | English | ||
| 13360724 | 10-Q | 2024-08-13 | English | ||
| 13360725 | FORM 8-K | 2024-08-13 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
MiNK Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34471/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34471 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34471 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34471 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34471}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for MiNK Therapeutics, Inc. (id: 34471)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.